Acrux Ltd
Company Profile
Business description
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.
Contact
103-113 Stanley Street
West Melbourne
MelbourneVIC3003
AUST: +61 383790100
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
36
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,543.70 | 34.10 | -0.40% |
CAC 40 | 7,431.04 | 59.24 | -0.79% |
DAX 40 | 20,214.79 | 102.31 | -0.50% |
Dow JONES (US) | 41,938.45 | 696.75 | -1.63% |
FTSE 100 | 8,248.49 | 71.20 | -0.86% |
HKSE | 19,064.29 | 176.60 | -0.92% |
NASDAQ | 19,161.63 | 317.25 | -1.63% |
Nikkei 225 | 39,190.40 | 414.69 | -1.05% |
NZX 50 Index | 12,895.98 | 47.76 | -0.37% |
S&P 500 | 5,827.04 | 91.21 | -1.54% |
S&P/ASX 200 | 8,294.10 | 35.10 | -0.42% |
SSE Composite Index | 3,168.52 | 42.87 | -1.33% |